Cerebrospinal fluid nitrate levels in patients with multiple sclerosis

European Neurology

Volumn 41, Issue 1, 1999, Pages 44-47

  De Bustos, Fernando ^a   Navarro, José Antonio ^a   De Andrés, Clara ^c   Molina, José Antonio ^b   Jiménez Jiménez, Félix Javier ^d,e   Ortí Pareja, Miguel ^d   Gasalla, Teresa ^d   Tallón Barranco, Antonio ^d   Martínez Salio, Antonio ^b   Arenas, Joaquín ^a  

^a Department of Biochemistry ^*  (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^e C/ Corregidor Jose de Pasamonte   (Spain)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Nitrates; Nitric oxide; Plasma

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; NITRATE; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NITRATES;

EID: 0032954775     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007997     Document Type: Article

References (22)

1. Molina JA, Jiménez-Jiménez FJ, Orti-Pareja M, Navarro JA: The role of nitric oxide in neurodegeneration: Potential for pharmacological intervention. Drugs Aging 1998;12:251-259.
2. Bredt DS, Snyder SH: Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 1994;63:175-195.
3. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT: Update on the epidemiology of multiple sclerosis. Mayo Clinic Proc 1989;64:808-817.
4. Martyn C: The epidemiology of multiple sclerosis; in Matthews WB, Compston A, Allen IV, Martyn CN (eds): McAlpine's Multiple Sclerosis. Edinburgh, Churchill Livingstone, 1991, pp 3-40.
5. Allen I: Aeliological hypotheses for multiple sclerosis: Evidence from human and experimental diseases; in Matthews WB, Compston A, Allen IV, Martyn CN (eds): McAlpine's Multiple Sclerosis. Edinburgh, Churchill Livingstone, 1991, pp 379-390.
6. Poser CM: Multiple sclerosis. Observations and reflections - A personal memoir. J Neurol Sci 1992;107:127-140.
7. Boullerne AI, Petry KG, Meynard M, Geffard M: Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 1995;60:117-124.
8. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD: Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 36:778-786.
9. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H: Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995;92:12041-12045.
10. Johnson AW, Land JM, Thompson EJ, Bolanos JP, Clark JB, Heales SJ: Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 58:107.
11. 3-) levels in cerebrospinal fluid of patents with multiple sclerosis. J Neurol Sci 1997;153:32-34.
12. Ikeda M, Sato I, Matsunaga T, Takahashi M, Yuasa T, Murota S: Cyclic guanosinc monophosphate (cGMP). nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. Intern Med 1995;34:734-737.
13. Poser CM, Paty D, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.
14. Wennmalm A, Benthin G, Petersson AS: Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygénation of its red cell haemoglobin. Br J Pharmacol 1992;106:507-508.
15. Wennmalm A, Lanne B, Petersson AS: Detection of endothelial-derived relaxing factors in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal Biochem 1990;187: 359-363.
16. Mordvinteev P, Mulsch A, Busse R, Vanin A: On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem 1991; 199:142-146.
17. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
18. Navarro-Gonzálvez JA, García-Benayas C, Arenas J: Semiautomated measurement of nitrate in biological fluids. Clin Chem 1998;44: 679-681.
19. Morcu E, Molinero LM, Fernández E: R-Sigma: Base de datos bioestadística para un ordenador personal. Madrid, Horus Hardware, 1990.
20. Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaiko T, Maeda H, Koprowski H: Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997;94:2528-2533.
21. Giovannoni G, Heales SJ, Silver NC, O'Riordan J, Miller RF, Land SM, Clark SB, Thompson EJ: Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 1997;145:77-81.
22. 15N-nitrate in biological fluids. Anal Biochem 1982;126:131-138.